CONCLUSION
In summary, our study demonstrated that Empagliflozin effectively ameliorated HFD/STZ-induced liver fibrosis in T2DM mice through increasing cecal relative abundance of Lactobacillus and reducing the abundance ofRuminococcus and Adlercreutzia , which might be a novel therapeutic direction for liver fibrosis (Supplementary Figure 4).
MATERIALS AND METHODS